ADVFN - Advanced Financial Network.
HOME» NYSE » M » MRK Stock Price » MRK Stock News

Merck Share News

 Merck & Co., Stock Price
MRK Stock Price
 Merck & Co., Stock Chart
MRK Stock Chart
 Merck & Co., Stock News
MRK Stock News
 Merck & Co., Company Information
MRK Company Information
 Merck & Co., Stock Trades
MRK Stock Trades

Bristol-Myers Gets SEC Subpoena In Foreign Bribery Probe

By Peter Loftus Of DOW JONES NEWSWIRES Drug maker Bristol-Myers Squibb Co. (BMY) said it has received a subpoena from the U.S. Securities and Exchange Commission as part of an investigation into bribery overseas. Bristol-Myers said the subpoena received in March seeks information related to sales and marketing practices in "various countries." The New York-based company said in a quarterly report filed Thursday with the SEC that it was cooperating with the government. A spokeswoman declined comment beyond the information in Thursday's SEC filing. Bristol-Myers, which sells the anti-clotting drug Plavix, previously disclosed that the SEC was investigating the activities of the company's units in Germany, concerning potential violations of the U.S. Foreign Corrupt Practices Act, or FCPA. U.S. authorities in recent years have stepped up enforcement of the FCPA, which bars U.S. companies from bribing foreign officials to obtain or retain business. Multinational drug and medical-device makers based in the U.S. have been among the targets of enforcement. Last year, Johnson & Johnson (JNJ) agreed to pay nearly $80 million to resolve allegations that it paid bribes to doctors in three European countries, as well as kickbacks to Iraq to illegally obtain business under former leader Saddam Hussein. Other drug makers--including Pfizer Inc. (PFE), Merck & Co. (MRK) and Eli Lilly & Co. (LLY)--also have been the subjects of federal inquiries regarding the FCPA. -By Peter Loftus, Dow Jones Newswires; +1-215-982-5581; peter.loftus@dowjones.com

Stock News for Merck (MRK)
DateTimeHeadline
11/24/201409:57:19Bristol-Myers, Five Prime to Collaborate on Immunotherapy
11/17/201411:41:20U.S. Stocks Bounce Back from Early Loses
11/17/201405:11:44Pfizer, Germany's Merck to Develop Tumor Treatment -- Update
10/27/201416:37:41MARKET SNAPSHOT: Energy Stocks Sap S&P 500
10/27/201414:06:16MARKET SNAPSHOT: U.S. Stocks Retreat; Energy Stocks Sell Off
10/27/201411:51:27MARKET SNAPSHOT: U.S. Stock Retreat; Energy Stocks Sell Off
10/27/201411:47:43MARKET SNAPSHOT: U.S. Stock: Futures Fall; Focus On Fed
10/27/201411:40:15MARKET SNAPSHOT: Stock Futures Flatten After Weak German Data;...
10/26/201405:18:37MARKET SNAPSHOT: Energy, Health Care Earnings To Dominate Week
10/02/201410:57:10EUROPE MARKETS: European Stocks Flop As ECB's Draghi Talks Stimulus
10/02/201410:10:14EUROPE MARKETS: European Stocks Fall As ECB's Draghi Talks Stimulus
10/02/201408:45:12EUROPE MARKETS: European Stocks Fall; ECB Watched For Stimulus...
10/02/201405:53:22EUROPE MARKETS: European Stocks Fall; ECB Stimulus Details On...
10/02/201403:50:10Bayer Sells $7 Billion Bond
10/01/201418:10:29Esperion Reports Favorable Cholesterol Drug Data
10/01/201417:58:21Esperion Reports Favorable Cholesterol Drug Data -- Update
09/29/201417:56:12Doctor Group Backs Implantable Devices to Prevent Teen Pregnancies
09/24/201421:28:09Correction to Dow Index Overseers Correction
09/24/201421:08:41Correction to Dow Index Overseers Story
09/24/201419:57:00Dow Index Overseers Make It Official: U.S. Firms Only

Merck and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad